MILGAMMA N

40MG/90MG/0,25MG CPS MOL 100

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 09.04.2019
Resumption of marketing 20.12.2018
Interruption of marketing 30.11.2018 0013816
Capacity/distribution reasons leden 2019
Resumption of marketing 10.04.2017

All reports are available in the Overview.

Back to list